Daily non-political popular news in brief.
Novel test identifies lymphoma patients likely to respond to new therapy
02-20-2007 · EurekAlert!Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.
Read more »
Keywords: novel, test, identifies, lymphoma, patients, likely, respond, therapy, identify, patient
« Previous | Next »
Similar news on "Novel test identifies lymphoma patients likely to respond to new therapy":
- Novel test identifies leukemia patients likely to respond to new therapy
02-20-2007 · EurekAlert!
Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.
Similar news · Read more »
- Molecules might identify high-risk acute-leukemia patients
01-15-2008 · EurekAlert!
New research suggests that certain microRNAs might help doctors identify adult acute-leukemia patients who are likely to respond poorly to therapy. The findings showed that both the leukemia cells and their normal counterparts had similar kinds of microRNA, but that the two groups differed in the levels of miRNAs present. The study should improve the understanding of acute myeloid leukemia and could lead to new therapies for patients with few treatment options.
Similar news · Read more »
- Simple two-in-one test signals high risk after a heart attack
12-03-2007 · EurekAlert!
Everyone loves a two-fer, but a two-in-one heart test that has the potential to save lives is the real deal. According to new research, pairing two findings from one simple test makes it significantly more likely that doctors will identify patients who face the greatest risk after a heart attack.
Similar news · Read more »
- Advanced therapy offers cure for relapsed cancer patient
07-25-2007 · EurekAlert!
Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine study by Lawrence Einhorn, M.D.; Stephen Williams, M.D.; Rafat Abonour, M.D., and colleagues published in the July 26 issue of the New England Journal of Medicine. Although the number of relapsed testicular cancer patients in the US is small, the IU Simon Cancer Center treats a majority of them.
Similar news · Read more »
- Study identifies characteristics of clinicians likely to order inappropriate prostate screenings
07-09-2007 · EurekAlert!
Prostate-specific antigen tests to screen for prostate cancer are frequently performed among patients for whom the PSA test is not shown to be beneficial, and clinicians with certain characteristics are more likely to order such inappropriate screening tests, according to a report in the July 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Similar news · Read more »
- Study identifies women with breast cancer most likely to benefit from aromatase inhibitor
10-23-2006 · EurekAlert!
While some breast cancer survivors could benefit from adding aromatase inhibitors to the standard five years of tamoxifen, a new study shows the additional therapy should be weighed carefully for each individual. Tthe study's authors say potential improvement in cancer-free survival beyond five years with the added therapy may be less than two percent for most patients.
Similar news · Read more »
- Genetic approach provides new insight into trastuzumab resistance in breast cancer
10-15-2007 · EurekAlert!
A new study provides important insight into the mechanisms involved in resistance to treatment of breast cancer patients with trastuzumab (Herceptin). The research, published by Cell Press in the October issue of the journal Cancer Cell, identifies markers that may help to identify patients who are unlikely to respond to trastuzumab treatment and provides a potential strategy for treating these patients.
Similar news · Read more »
- UF researchers test stem cell therapy for heart patients
10-04-2007 · EurekAlert!
University of Florida doctors treated the first patient in a new study to test whether a person's own stem cells can be used to restore blood flow to the heart by prompting new blood vessels to grow.
Similar news · Read more »
- Personalized diets may offer relief to advanced cancer patients
03-09-2007 · EurekAlert!
Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
Similar news · Read more »
- Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
09-06-2007 · EurekAlert!
A new study has found an unexpected number of viruses and viral subtypes in patients with respiratory tract infections. The technique used in the study may help identify new viruses associated with human diseases. The study is published in the Sept. 15 issue of the Journal of Infectious Diseases, now available online.
Similar news · Read more »
